Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR Transformylase Homodimerization

Ian B. Spurr, Charles N. Birts, Francesco Cuda, Stephen J. Benkovic, Jeremy P. Blaydes, Ali Tavassoli

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

Aminoimidazole carboxamide ribonucleotide transformylase/ inosine monophosphate cyclohydrolase (ATIC) is a bifunctional homodimeric enzyme that catalyzes the last two steps of de novo purine biosynthesis. Homodimerization of ATIC, a protein-protein interaction with an interface of over 5000 Å2, is required for its aminoimidazole carboxamide ribonucleotide (AICAR) transformylase activity, with the active sites forming at the interface of the interacting proteins. Here, we report the development of a small-molecule inhibitor of AICAR transformylase that functions by preventing the homodimerization of ATIC. The compound is derived from a previously reported cyclic hexapeptide inhibitor of AICAR transformylase (with a Ki of 17 μM), identified by high-throughput screening. The active motif of the cyclic peptide is identified as an arginine-tyrosine dipeptide, a capped analogue of which inhibits AICAR transformylase with a Ki value of 84 μM. A library of nonnatural analogues of this dipeptide was designed, synthesized, and assayed. The most potent compound inhibits AICAR transformylase with a Ki value of 685 nM, a 25-fold improvement in activity from the parent cyclic peptide. The potential for this AICAR transformylase inhibitor in cancer therapy was assessed by studying its effect on the proliferation of a model breast cancer cell line. Using a nonradioactive proliferation assay and live cell imaging, a dose-dependent reduction in cell numbers and cell division rates was observed in cells treated with our ATIC dimerization inhibitor.

Original languageEnglish (US)
Pages (from-to)1628-1634
Number of pages7
JournalChemBioChem
Volume13
Issue number11
DOIs
StatePublished - Jul 23 2012

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR Transformylase Homodimerization'. Together they form a unique fingerprint.

  • Cite this

    Spurr, I. B., Birts, C. N., Cuda, F., Benkovic, S. J., Blaydes, J. P., & Tavassoli, A. (2012). Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR Transformylase Homodimerization. ChemBioChem, 13(11), 1628-1634. https://doi.org/10.1002/cbic.201200279